Study of Amrubicin With or Without Cisplatin Versus Etoposide-cisplatin for Extensive Stage Small Cell Lung Cancer

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Celgene Corporation

ClinicalTrials.gov Identifier:

NCT00388960

First received: October 13, 2006

Last updated: March 27, 2013

Last verified: April 2011

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	December 2010
Primary Completion Date:	April 2010 (Final data collection date for primary outcome measure)
Certification or Request for Extension to Delay Results Received:	May 31, 2012